{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T01:33:03Z","timestamp":1794879183949,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007195","name":"Universit\u00e0 degli Studi di Napoli Federico II","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007195","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To compare dual triggering versus hCG-only triggering in poor responders undergoing controlled ovarian stimulation with a GnRH antagonist protocol in ART cycles.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review and meta-analysis was performed. The primary outcome was the number of mature oocytes (MII). The number of oocytes retrieved, clinical pregnancy, and miscarriage rates were analyzed as secondary outcomes. Subgroup analyses were conducted according to the Bologna and POSEIDON classifications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Ten studies were included. Dual triggering significantly increased the number of retrieved and mature oocytes in patients classified according to the Bologna criteria, but not in those classified by the POSEIDON criteria. Age-related differences across studies appeared to influence the efficacy of dual triggering. A borderline improvement in clinical pregnancy rates was observed among Bologna-defined patients. Miscarriage rates did not differ significantly between the groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Dual triggering appears to improve oocyte yield and maturity in Bologna-defined patients, but this effect is unlikely to apply uniformly across all phenotypes. Persistent heterogeneity in poor responder definitions limits the understanding of the benefits of dual triggering in this population. Well-designed prospective studies with rigorous phenotypic stratification are warranted to identify which patients are most likely to benefit from dual triggering.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10815-026-03821-5","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:39:47Z","timestamp":1770417587000},"page":"1063-1077","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of dual triggering in poor ovarian responders defined according to Bologna and POSEIDON criteria: a systematic review with meta-analysis"],"prefix":"10.1007","volume":"43","author":[{"given":"Antonio","family":"Mercorio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Conforti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Pluchino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Drakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Giudice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Giampaolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Vallee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vehbi Yavuz","family":"Tokgoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Alviggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Marc","family":"Ayoubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"3821_CR1","doi-asserted-by":"crossref","unstructured":"Gonen Y, Balakier H, Powell W, Casper RF. Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization.\u00a0J Clin Endocrinol Metab.\u00a01990;71(4):918\u2013922.","DOI":"10.1210\/jcem-71-4-918"},{"key":"3821_CR2","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2023.2205952","author":"M Fern\u00e1ndez-S\u00e1nchez","year":"2023","unstructured":"Fern\u00e1ndez-S\u00e1nchez M, Fatemi H, Garc\u00eda-Velasco JA, Heiser PW, Daftary GS, Mannaerts B. Incidence and severity of ovarian hyperstimulation syndrome (OHSS) in high responders after gonadotropin-releasing hormone (GnRH) agonist trigger in \u201cfreeze-all\u201d approach. Gynecol Endocrinol. 2023. https:\/\/doi.org\/10.1080\/09513590.2023.2205952.","journal-title":"Gynecol Endocrinol"},{"key":"3821_CR3","doi-asserted-by":"crossref","unstructured":"Ali SS, Elsenosy E, Sayed GH, et al. Dual trigger using recombinant HCG and gonadotropin-releasing hormone agonist improve oocyte maturity and embryo grading for normal responders in GnRH antagonist cycles: Randomized controlled trial.\u00a0J Gynecol Obstet Hum Reprod. 2020;49(5):101728.","DOI":"10.1016\/j.jogoh.2020.101728"},{"key":"3821_CR4","doi-asserted-by":"crossref","unstructured":"Griffin D, Feinn R, Engmann L, Nulsen J, Budinetz T, Benadiva C. Dual trigger with gonadotropin-releasing hormone agonist and Standard dose human chorionic gonadotropin to improve oocyte maturity rates.\u00a0Fertil Steril.\u00a02014;102(2):405\u20139.","DOI":"10.1016\/j.fertnstert.2014.04.028"},{"key":"3821_CR5","doi-asserted-by":"crossref","unstructured":"Di Guardo F, Pluchino N, Drakopoulos P. Treatment modalities for poor ovarian responders.\u00a0Ther Adv Reprod Health. 2023;17:26334941221147464.","DOI":"10.1177\/26334941221147464"},{"key":"3821_CR6","doi-asserted-by":"crossref","unstructured":"Giovanale V, Pulcinelli FM, Ralli E, Primiero FM, Caserta D.\u00a0Poor responders in IVF: an update in therapy.\u00a0Gynecol Endocrinol. 2015;31(4):253\u2013257.","DOI":"10.3109\/09513590.2014.987228"},{"key":"3821_CR7","doi-asserted-by":"crossref","unstructured":"Polyzos NP, Devroey P. A systematic review of randomized trials for\u00a0the\u00a0treatment of poor ovarian responders: is\u00a0there\u00a0any light at the end of the tunnel?\u00a0Fertil Steril. 2011;96(5):1058\u201361.e7.","DOI":"10.1016\/j.fertnstert.2011.09.048"},{"issue":"7","key":"3821_CR8","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","volume":"26","author":"AP Ferraretti","year":"2011","unstructured":"Ferraretti AP, La Marca A, Fauser BCJM, Tarlatzis B, Nargund G, Gianaroli L. ESHRE consensus on the definition of \u2018poor response\u2019 to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26(7):1616\u201324. https:\/\/doi.org\/10.1093\/humrep\/der092.","journal-title":"Hum Reprod"},{"key":"3821_CR9","doi-asserted-by":"crossref","unstructured":"Ferraretti AP, Gianaroli L. The Bologna criteria for the definition of poor ovarian responders: is there a need for revision?.\u00a0Hum Reprod. 2014;29(9):1842\u20131845.","DOI":"10.1093\/humrep\/deu139"},{"key":"3821_CR10","doi-asserted-by":"crossref","unstructured":"Alviggi C, Andersen CY, et al. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept.\u00a0Fertil Steril. 2016;105(6):1452\u20131453.","DOI":"10.1016\/j.fertnstert.2016.02.005"},{"issue":"3","key":"3821_CR11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/09513590.2021.2000962","volume":"38","author":"A Sloth","year":"2022","unstructured":"Sloth A, Kj\u00f8lhede M, Sarmon KG, Knudsen UB. Effect of dual trigger on reproductive outcome in low responders: a systematic PRISMA review and meta-analysis. Gynecol Endocrinol. 2022;38(3):213\u201321. https:\/\/doi.org\/10.1080\/09513590.2021.2000962.","journal-title":"Gynecol Endocrinol"},{"key":"3821_CR12","doi-asserted-by":"crossref","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.\u00a0Ann Intern Med. 2009;151(4):264-W64.","DOI":"10.7326\/0003-4819-151-4-200908180-00135"},{"key":"3821_CR13","doi-asserted-by":"crossref","unstructured":"Zegers-Hochschild F, Adamson GD, Dyer S, et al. The International Glossary on Infertility and Fertility Care, 2017.\u00a0Hum Reprod. 2017;32(9):1786\u20131801.","DOI":"10.1093\/humrep\/dex234"},{"key":"3821_CR14","doi-asserted-by":"crossref","unstructured":"Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample.\u00a0BMC Med Res Methodol. 2005;5:13.","DOI":"10.1186\/1471-2288-5-13"},{"issue":"2","key":"3821_CR15","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","volume":"56","author":"S Duval","year":"2000","unstructured":"Duval S, Tweedie R. Trim and fill: a simple funnel-plot\u2013based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455\u201363. https:\/\/doi.org\/10.1111\/j.0006-341X.2000.00455.x.","journal-title":"Biometrics"},{"key":"3821_CR16","doi-asserted-by":"crossref","unstructured":"Keskin M, Ecemi\u015f T, Atik A, Ye\u011fen P, Kalkan E, Y\u00fccel GS. Cycle outcomes of dual trigger (GnRH agonist+hCG) versus human chorionic gonadotropin trigger alone in POSEDION group 3\u20134 poor-responders and normo-responders: A prospective randomized study.\u00a0J Gynecol Obstet Hum Reprod. 2023;52(8):102633.","DOI":"10.1016\/j.jogoh.2023.102633"},{"key":"3821_CR17","doi-asserted-by":"crossref","unstructured":"Tulek F, Kahraman A, Demirel LC Dual\u00a0trigger\u00a0with gonadotropin releasing hormone agonist and human chorionic gonadotropin improves live birth rates in POSEIDON group 3 and 4 expected\u00a0poor\u00a0responders. Gynecol Endocrinol. 2022;38(9):731\u2013735.","DOI":"10.1080\/09513590.2022.2101635"},{"key":"3821_CR18","doi-asserted-by":"crossref","unstructured":"Chern CU, Li JY, Tsui KH, Wang PH, Wen ZH, Lin LT. Dual-trigger improves the outcomes of in vitro fertilization cycles in older patients with diminished ovarian reserve: a retrospective cohort study.\u00a0PLoS One. 2020;15(7):e0235707.","DOI":"10.1371\/journal.pone.0235707"},{"key":"3821_CR19","doi-asserted-by":"publisher","unstructured":"Ozer G, Ozmen S. Dual trigger does not improve the results of in vitro fertilization cycles in POSEIDON group 3: A retrospective cohort study. Ann Clin Anal Med.\u00a02023.\u00a0https:\/\/doi.org\/10.4328\/ACAM.21873.\u00a0","DOI":"10.4328\/ACAM.21873"},{"key":"3821_CR20","doi-asserted-by":"crossref","unstructured":"Maged AM, Ragab MA, Shohayeb A, et al. Comparative study between single versus dual trigger for poor responders in GnRH-antagonist ICSI cycles: a randomized controlled study.\u00a0Int J Gynaecol Obstet. 2021;152(3):395\u2013400.","DOI":"10.1002\/ijgo.13405"},{"key":"3821_CR21","doi-asserted-by":"crossref","unstructured":"Mutlu I, Demirdag E, Cevher F, Erdem A, Erdem M. Dual trigger with the combination of gonadotropin-releasing hormone agonist and standard dose of human chorionic gonadotropin improves\u00a0in\u00a0vitro\u00a0fertilisation outcomes in poor ovarian responders.\u00a0J Obstet Gynaecol. 2022;42(5):1239\u20131244.","DOI":"10.1080\/01443615.2021.1945560"},{"key":"3821_CR22","doi-asserted-by":"crossref","unstructured":"Eser A, Devrano\u011flu B, Bostanc\u0131 Ergen E, Yayla Abide \u00c7. Dual trigger with gonadotropin-releasing hormone and human chorionic gonadotropin for poor responders.\u00a0J Turk Ger Gynecol Assoc. 2018;19(2):98\u2013103.","DOI":"10.4274\/jtgga.2017.0045"},{"issue":"6","key":"3821_CR23","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.rbmo.2017.09.002","volume":"35","author":"J Zhang","year":"2017","unstructured":"Zhang J, Wang Y, Mao X, et al. Dual trigger of final oocyte maturation in poor ovarian responders undergoing IVF\/ICSI cycles. Reprod Biomed Online. 2017;35(6):701\u20137.","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"3821_CR24","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.mefs.2018.04.011","volume":"23","author":"M Eftekhar","year":"2018","unstructured":"Eftekhar M, Naghshineh E, Neghab N, et al. A comparison of dual triggering (by administration of GnRH agonist plus HCG) versus HCG alone in poor ovarian responders in ART outcomes. Middle East Fertil Soc J. 2018;23(4):350\u20133.","journal-title":"Middle East Fertil Soc J"},{"issue":"4","key":"3821_CR25","doi-asserted-by":"publisher","first-page":"246","DOI":"10.5935\/1518-0557.20160047","volume":"20","author":"SA Oliveira","year":"2016","unstructured":"Oliveira SA, Calsavara VF, Cort\u00e9s GC. Final oocyte maturation in assisted reproduction with human chorionic gonadotropin and gonadotropin-releasing hormone agonist (dual trigger). JBRA Assist Reprod. 2016;20(4):246\u201350.","journal-title":"JBRA Assist Reprod"},{"issue":"1","key":"3821_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00404-018-4751-3","volume":"298","author":"CH Chen","year":"2018","unstructured":"Chen CH, Tzeng CR, Wang PH, et al. Dual triggering with GnRH agonist plus hCG versus triggering with hCG alone for IVF\/ICSI outcome in GnRH antagonist cycles: a systematic review and meta-analysis. Arch Gynecol Obstet. 2018;298(1):17\u201326 ([Cross Ref] [Pub Med]).","journal-title":"Arch Gynecol Obstet"},{"issue":"9","key":"3821_CR27","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1093\/humrep\/deu135","volume":"29","author":"A Papathanasiou","year":"2014","unstructured":"Papathanasiou A. Implementing the ESHRE \u201cpoor responder\u201d criteria in research studies: methodological implications. Hum Reprod. 2014;29(9):1835\u20138.","journal-title":"Hum Reprod"},{"key":"3821_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.587051","volume":"12","author":"SC Esteves","year":"2021","unstructured":"Esteves SC, Conforti A, Sunkara SK, Carbone L, Picarelli S, Vaiarelli A, et al. Improving reporting of clinical studies using the POSEIDON criteria: POSORT guidelines. Front Endocrinol (Lausanne). 2021;12:587051. https:\/\/doi.org\/10.3389\/fendo.2021.587051.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"3821_CR29","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.rbmo.2017.06.015","volume":"35","author":"ESHRE Special Interest Group of Embryology; Alpha Scientists in Reproductive Medicine","year":"2017","unstructured":"ESHRE Special Interest Group of Embryology; Alpha Scientists in Reproductive Medicine. The Vienna consensus: report of an expert meeting on the development of ART laboratory performance indicators. Reprod Biomed Online. 2017;35(5):494\u2013510. https:\/\/doi.org\/10.1016\/j.rbmo.2017.06.015.","journal-title":"Reprod Biomed Online"},{"key":"3821_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0176019","volume":"12","author":"V Gunnala","year":"2017","unstructured":"Gunnala V, Melnick A, Irani M, et al. Sliding scale hCG trigger yields equivalent pregnancy outcomes and reduces OHSS: analysis of 10,427 IVF\u2013ICSI cycles. PLoS ONE. 2017;12:e0176019. https:\/\/doi.org\/10.1371\/journal.pone.0176019.","journal-title":"PLoS ONE"},{"key":"3821_CR31","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.fertnstert.2017.05.016","volume":"108","author":"TNL Vuong","year":"2017","unstructured":"Vuong TNL, Ho MT, Ha TD, et al. Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a GnRH antagonist: a dose-finding study. Fertil Steril. 2017;108:257-263.e1. https:\/\/doi.org\/10.1016\/j.fertnstert.2017.05.016.","journal-title":"Fertil Steril"},{"key":"3821_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008046.pub2","volume":"1","author":"MA Youssef","year":"2011","unstructured":"Youssef MA, Abou-Setta AM, Lam WS. Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles. Cochrane Database Syst Rev. 2011;1:CD008046. https:\/\/doi.org\/10.1002\/14651858.CD008046.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"3821_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/humupd\/dmr037","volume":"18","author":"JF Oudendijk","year":"2012","unstructured":"Oudendijk JF, Yarde F, Eijkemans MJ, Broekmans FJ, Broer SL. The poor responder in IVF: is the prognosis always poor?: a systematic review. Hum Reprod Update. 2012;18(1):1\u201311 ([Cross Ref] [Pub Med]).","journal-title":"Hum Reprod Update"},{"key":"3821_CR34","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1093\/humrep\/der106","volume":"26","author":"SK Sunkara","year":"2011","unstructured":"Sunkara SK, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J, Coomarasamy A. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod. 2011;26:1768\u201374 ([Cross Ref] [Pub Med]).","journal-title":"Hum Reprod"}],"updated-by":[{"DOI":"10.1007\/s10815-026-03845-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000}}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-026-03821-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-026-03821-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-026-03821-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T09:57:14Z","timestamp":1776851834000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-026-03821-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["3821"],"URL":"https:\/\/doi.org\/10.1007\/s10815-026-03821-5","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"27 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: The fourth author's name was incorrectly spelled as \"Panagiotis Drakopulos.\" It should be \"Panagiotis Drakopoulos\".","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10815-026-03845-x","URL":"https:\/\/doi.org\/10.1007\/s10815-026-03845-x","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}